AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (4.6 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

Aminopyridine treatment for an adult patient of developmental and epileptic encephalopathy with a gain-of-function mutation in KCNA2

Lehong Gaoa,b,e( )Yu Jiaa,b,eYingxue Yanga,bJia Chena,bLiankun Rena,b,c,d( )
Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
Clinical Research Center of Epilepsy, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
National Center for Neurological Disorders, Beijing 100053, China
Chinese Institute for Brain Research, Beijing 102206, China

e These authors contributed equally to this work.

Peer review under the responsibility of Chongqing Medical University.

Show Author Information

References

【1】
【1】
 
 
Genes & Diseases

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Gao L, Jia Y, Yang Y, et al. Aminopyridine treatment for an adult patient of developmental and epileptic encephalopathy with a gain-of-function mutation in KCNA2. Genes & Diseases, 2026, 13(4). https://doi.org/10.1016/j.gendis.2025.101798

5

Views

0

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 03 April 2025
Published: 07 August 2025
© 2026

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).